Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.10 (
IKK
)
4,900
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Follicular helper T (T
FH
) cells represent a highly specialized CD4
+
T cell subpopulation that supports the generation of germinal centers (GC) and provides B cells with critical signals promoting antibody class switching, generation of high affinity antibodies, and memory formation. T
FH
cells are characterized by the expression of the chemokine receptor
CXCR5
, the transcription factor Bcl-6, costimulatory molecules ICOS, and PD-1, and the production of cytokine IL-21. The acquisition of a T
FH
phenotype is a complex and multistep process that involves signals received through engagement of the TCR along with a multitude of costimulatory molecules and cytokines receptors. Members of the Tumor necrosis factor Receptor Associated Factors (TRAF) represent one of the major classes of signaling mediators involved in the differentiation and functions of T
FH
cells. TRAF molecules are the canonical adaptor molecules that physically interact with members of the Tumor Necrosis Factor Receptor Superfamily (TNFRSF) and actively modulate their downstream signaling cascades through their adaptor function and/or E3 ubiquitin ligase activity. OX-40, GITR, and 4-1BB are the TRAF-dependent TNFRSF members that have been implicated in the differentiation and functions of T
FH
cells. On the other hand, emerging data demonstrate that TRAF proteins also participate in signaling from the TCR and CD28, which deliver critical signals leading to the differentiation of T
FH
cells. More intriguingly, we recently showed that the cytoplasmic tail of ICOS contains a conserved
TANK-binding kinase 1
(
TBK1
)-binding motif that is shared with
TBK1
-binding TRAF proteins. The presence of this TRAF-mimicking signaling module downstream of ICOS is required to mediate the maturation step during T
FH
differentiation. In addition, JAK-STAT pathways emanating from IL-2, IL-6, IL-21, and IL-27 cytokine receptors affect T
FH
development, and crosstalk between TRAF-mediated pathways and the JAK-STAT pathways can contribute to generate integrated signals required to drive and sustain T
FH
differentiation. In this review, we will introduce the molecular interactions and the major signaling pathways controlling the differentiation of T
FH
cells. In each case, we will highlight the contributions of TRAF proteins to these signaling pathways. Finally, we will discuss the role of individual TRAF proteins in the regulation of T cell-dependent humoral responses.
...
PMID:Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses. 3040 12
T follicular helper (T
fh
) cells have emerged as a critical limiting factor for controlling the magnitude of neonatal germinal center (GC) reactions and primary vaccine antibody responses. We compared the functional attributes of neonatal and adult T
fh
cells at the transcriptomic level and demonstrated that the T
fh
cell program is well-initiated in neonates although the T
fh
gene-expression pattern (i.e.,
CXCR5
, IL-21, BCL6,
TBK1
, STAT4, ASCL2
, and
c-MAF
) is largely underrepresented as compared to adult T
fh
cells. Importantly, we identified a TH2-bias of neonatal T
fh
cells, with preferential differentiation toward short-lived pre-T
fh
effector cells. Remarkably, adjuvantation with CpG-ODNs redirect neonatal pre-T
fh
cells toward committed GC-T
fh
cells, as illustrated by increased expression of T
fh
signature genes and reduced expression of TH2-related genes.
...
PMID:Neonatal T Follicular Helper Cells Are Lodged in a Pre-T Follicular Helper Stage Favoring Innate Over Adaptive Germinal Center Responses. 3145 98
